press_release_conclusion: Medical devices approved first in the European Union (EU) are associated with a greater rate of safety issues, finds a study published by The BMJ today.
abstract_conclusion: Devices approved first in the EU are associated with an increased risk of post-marketing safety alerts and recalls.